Cargando…
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update
Survival rates for patients with medulloblastoma have improved in the last decades but for those who relapse outcome is dismal and new approaches are needed. Emerging drugs have been tested in the last two decades within the context of phase I/II trials. In parallel, advances in genetic profiling ha...
Autores principales: | Bautista, Francisco, Fioravantti, Victoria, de Rojas, Teresa, Carceller, Fernando, Madero, Luis, Lassaletta, Alvaro, Moreno, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673921/ https://www.ncbi.nlm.nih.gov/pubmed/28980418 http://dx.doi.org/10.1002/cam4.1171 |
Ejemplares similares
-
Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma
por: Guo, Yuduo, et al.
Publicado: (2021) -
Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma
por: Wolle, Daniel, et al.
Publicado: (2014) -
Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation
por: Bassett, Erin A, et al.
Publicado: (2016) -
Jak2-mediated phosphorylation of Atoh1 is critical for medulloblastoma growth
por: Klisch, Tiemo J, et al.
Publicado: (2017) -
The RAGE/multiligand axis: a new actor in tumor biology
por: Rojas, Armando, et al.
Publicado: (2022)